• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

南非西开普省广泛耐药结核的空间异质性。

Spatial heterogeneity of extensively drug resistant-tuberculosis in Western Cape Province, South Africa.

机构信息

Department of Epidemiology, Boston University School of Public Health, Boston, MA, USA.

Department of Biostatistics, Boston University School of Public Health, Boston, MA, USA.

出版信息

Sci Rep. 2022 Jun 27;12(1):10844. doi: 10.1038/s41598-022-14581-4.

DOI:10.1038/s41598-022-14581-4
PMID:35760977
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9237070/
Abstract

Tuberculosis (TB) remains a leading infectious disease killer globally. Treatment outcomes are especially poor among people with extensively drug-resistant (XDR) TB, until recently defined as rifampicin-resistant (RR) TB with resistance to an aminoglycoside (amikacin) and a fluoroquinolone (ofloxacin). We used laboratory TB test results from Western Cape province, South Africa between 2012 and 2015 to identify XDR-TB and pre-XDR-TB (RR-TB with resistance to one second-line drug) spatial hotspots. We mapped the percentage and count of individuals with RR-TB that had XDR-TB and pre-XDR-TB across the province and in Cape Town, as well as amikacin-resistant and ofloxacin-resistant TB. We found the percentage of pre-XDR-TB and the count of XDR-TB/pre-XDR-TB highly heterogeneous with geographic hotspots within RR-TB high burden areas, and found hotspots in both percentage and count of amikacin-resistant and ofloxacin-resistant TB. The spatial distribution of percentage ofloxacin-resistant TB hotspots was similar to XDR-TB hotspots, suggesting that fluoroquinolone-resistace is often the first step to additional resistance. Our work shows that interventions used to reduce XDR-TB incidence may need to be targeted within spatial locations of RR-TB, and further research is required to understand underlying drivers of XDR-TB transmission in these locations.

摘要

结核病(TB)仍然是全球主要的传染病杀手。在广泛耐药(XDR)结核病患者中,治疗效果尤其不佳,直到最近才将其定义为耐利福平(RR)结核病,对氨基糖苷类(阿米卡星)和氟喹诺酮类(氧氟沙星)具有耐药性。我们使用南非西开普省 2012 年至 2015 年期间的实验室结核病检测结果,确定了 XDR-TB 和预 XDR-TB(对一种二线药物耐药的 RR-TB)的空间热点。我们绘制了全省和开普敦的 RR-TB 中具有 XDR-TB 和预 XDR-TB 的个体的百分比和数量,以及阿米卡星耐药和氧氟沙星耐药的结核病。我们发现,在 RR-TB 高负担地区内,预 XDR-TB 的百分比和 XDR-TB/预 XDR-TB 的数量存在高度异质性,并且在阿米卡星耐药和氧氟沙星耐药的结核病的百分比和数量上都存在热点。氟喹诺酮耐药结核病热点的空间分布与 XDR-TB 热点相似,这表明氟喹诺酮耐药性通常是产生其他耐药性的第一步。我们的工作表明,用于降低 XDR-TB 发病率的干预措施可能需要针对 RR-TB 的空间位置进行,还需要进一步研究这些地点中 XDR-TB 传播的潜在驱动因素。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3346/9237070/2f8febeb436f/41598_2022_14581_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3346/9237070/9d296510d3fd/41598_2022_14581_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3346/9237070/d76ec076bc02/41598_2022_14581_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3346/9237070/2f8febeb436f/41598_2022_14581_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3346/9237070/9d296510d3fd/41598_2022_14581_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3346/9237070/d76ec076bc02/41598_2022_14581_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3346/9237070/2f8febeb436f/41598_2022_14581_Fig3_HTML.jpg

相似文献

1
Spatial heterogeneity of extensively drug resistant-tuberculosis in Western Cape Province, South Africa.南非西开普省广泛耐药结核的空间异质性。
Sci Rep. 2022 Jun 27;12(1):10844. doi: 10.1038/s41598-022-14581-4.
2
Programmatically selected multidrug-resistant strains drive the emergence of extensively drug-resistant tuberculosis in South Africa.程序化选择的多药耐药株导致南非广泛耐药结核的出现。
PLoS One. 2013 Aug 23;8(8):e70919. doi: 10.1371/journal.pone.0070919. eCollection 2013.
3
Transmission, distribution and drug resistance-conferring mutations of extensively drug-resistant tuberculosis in the Western Cape Province, South Africa.南非西开普省广泛耐药结核病的传播、分布和耐药相关突变。
Microb Genom. 2022 Apr;8(4). doi: 10.1099/mgen.0.000815.
4
Treatment outcomes of patients with multidrug-resistant and extensively drug resistant tuberculosis in Hunan Province, China.中国湖南省耐多药和广泛耐药结核病患者的治疗结果
BMC Infect Dis. 2017 Aug 16;17(1):573. doi: 10.1186/s12879-017-2662-8.
5
High fluoroquinolone resistance proportions among multidrug-resistant tuberculosis driven by dominant L2 Mycobacterium tuberculosis clones in the Mumbai Metropolitan Region.高氟喹诺酮耐药比例在孟买大都市区由主导 L2 结核分枝杆菌克隆驱动的耐多药结核病中。
Genome Med. 2022 Aug 22;14(1):95. doi: 10.1186/s13073-022-01076-0.
6
Evolution of Extensively Drug-Resistant Tuberculosis over Four Decades: Whole Genome Sequencing and Dating Analysis of Mycobacterium tuberculosis Isolates from KwaZulu-Natal.四十年间广泛耐药结核病的演变:来自夸祖鲁 - 纳塔尔省结核分枝杆菌分离株的全基因组测序与年代分析
PLoS Med. 2015 Sep 29;12(9):e1001880. doi: 10.1371/journal.pmed.1001880. eCollection 2015 Sep.
7
Incidence and risk factors for extensively drug-resistant tuberculosis in Delhi region.德里地区广泛耐药结核病的发病率和危险因素。
PLoS One. 2013;8(2):e55299. doi: 10.1371/journal.pone.0055299. Epub 2013 Feb 4.
8
Epidemiology of extensively drug-resistant tuberculosis among patients with multidrug-resistant tuberculosis: A systematic review and meta-analysis.广泛耐药结核病患者中耐多药结核病的流行病学:系统评价和荟萃分析。
Int J Infect Dis. 2023 Jul;132:50-63. doi: 10.1016/j.ijid.2023.04.392. Epub 2023 Apr 16.
9
First Insight Into the Fluoroquinolone and Aminoglycoside Resistance of Multidrug-Resistant in Saudi Arabia.沙特阿拉伯对耐多药菌氟喹诺酮和氨基糖苷类耐药性的首次洞察。
Am J Trop Med Hyg. 2017 May;96(5):1066-1070. doi: 10.4269/ajtmh.16-0579.
10
Extensively drug-resistant tuberculosis in california, 1993-2006.1993 - 2006年加利福尼亚州的广泛耐药结核病
Clin Infect Dis. 2008 Aug 15;47(4):450-7. doi: 10.1086/590009.

引用本文的文献

1
Drug-Resistant Tuberculosis in Rural Eastern Cape, South Africa: A Study of Patients' Characteristics in Selected Healthcare Facilities.南非东开普省农村地区的耐多药结核病:对选定医疗机构中患者特征的研究
Int J Environ Res Public Health. 2024 Nov 30;21(12):1594. doi: 10.3390/ijerph21121594.
2
Patterns of HIV-1 Drug Resistance Observed Through Geospatial Analysis of Routine Diagnostic Testing in KwaZulu-Natal, South Africa.南非夸祖鲁-纳塔尔省常规诊断检测的地理空间分析观察到的 HIV-1 耐药模式。
Viruses. 2024 Oct 19;16(10):1634. doi: 10.3390/v16101634.
3
Accessibility of TB diagnostic services at primary healthcare clinics in the eThekwini district, South Africa: a geospatial analysis.

本文引用的文献

1
Decentralized Care for Rifampin-Resistant Tuberculosis, Western Cape, South Africa.南非西开普省耐利福平结核病的分散式护理。
Emerg Infect Dis. 2021;27(3):728-739. doi: 10.3201/eid2703.203204.
2
Using Bayesian spatial models to map and to identify geographical hotspots of multidrug-resistant tuberculosis in Portugal between 2000 and 2016.利用贝叶斯空间模型对 2000 年至 2016 年间葡萄牙耐多药结核病的地理热点进行绘制和识别。
Sci Rep. 2020 Oct 6;10(1):16646. doi: 10.1038/s41598-020-73759-w.
3
Switching to bedaquiline for treatment of rifampicin-resistant tuberculosis in South Africa: A retrospective cohort analysis.
南非埃滕哈赫区初级保健诊所结核病诊断服务的可达性:地理空间分析。
BMJ Open. 2024 Sep 23;14(9):e082129. doi: 10.1136/bmjopen-2023-082129.
4
Spatial Analysis of Drug-Susceptible and Multidrug-Resistant Cases of Tuberculosis, Ho Chi Minh City, Vietnam, 2020-2023.2020-2023 年越南胡志明市耐多药和敏感结核病病例的空间分析。
Emerg Infect Dis. 2024 Mar;30(3):499-509. doi: 10.3201/eid3003.231309.
5
Integrating Molecular Diagnostics and GIS Mapping: A Multidisciplinary Approach to Understanding Tuberculosis Disease Dynamics in South Africa Using Xpert MTB/RIF.整合分子诊断与地理信息系统绘图:一种运用Xpert MTB/RIF了解南非结核病疾病动态的多学科方法。
Diagnostics (Basel). 2023 Oct 10;13(20):3163. doi: 10.3390/diagnostics13203163.
在南非,改用贝达喹啉治疗利福平耐药结核病:一项回顾性队列分析。
PLoS One. 2019 Oct 17;14(10):e0223308. doi: 10.1371/journal.pone.0223308. eCollection 2019.
4
Spatiotemporal Clustering of Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis Is Associated With Human Immunodeficiency Virus Status and Drug-Susceptibility Patterns in KwaZulu-Natal, South Africa.时空聚集的耐多药和广泛耐药结核病与南非夸祖鲁-纳塔尔省的人类免疫缺陷病毒状况和药物敏感性模式有关。
Clin Infect Dis. 2020 May 6;70(10):2224-2227. doi: 10.1093/cid/ciz913.
5
Extensively drug-resistant tuberculosis 'hotspots' and sociodemographic associations in Durban, South Africa.南非德班地区广泛耐药结核病“热点”及其与社会人口学的关联。
Int J Tuberc Lung Dis. 2019 Jun 1;23(6):720-727. doi: 10.5588/ijtld.18.0575.
6
Using routinely collected laboratory data to identify high rifampicin-resistant tuberculosis burden communities in the Western Cape Province, South Africa: A retrospective spatiotemporal analysis.利用常规收集的实验室数据来识别南非西开普省高利福平耐药结核病负担社区:一项回顾性时空分析。
PLoS Med. 2018 Aug 21;15(8):e1002638. doi: 10.1371/journal.pmed.1002638. eCollection 2018 Aug.
7
Prevalence of drug-resistant tuberculosis and imputed burden in South Africa: a national and sub-national cross-sectional survey.南非耐药结核病的流行情况和估算负担:一项全国和次国家级的横断面调查。
Lancet Infect Dis. 2018 Jul;18(7):779-787. doi: 10.1016/S1473-3099(18)30222-6. Epub 2018 Apr 21.
8
MDR-TB patients in KwaZulu-Natal, South Africa: Cost-effectiveness of 5 models of care.南非夸祖鲁-纳塔尔省耐多药结核病患者:5 种护理模式的成本效益分析。
PLoS One. 2018 Apr 18;13(4):e0196003. doi: 10.1371/journal.pone.0196003. eCollection 2018.
9
Spatial clustering of drug-resistant tuberculosis in Hlabisa subdistrict, KwaZulu-Natal, 2011-2015.2011-2015 年夸祖鲁-纳塔尔省赫拉巴伊斯地区耐多药结核病的空间聚集性
Int J Tuberc Lung Dis. 2018 Mar 1;22(3):287-293. doi: 10.5588/ijtld.17.0457.
10
Spatial distribution of extensively drug-resistant tuberculosis (XDR TB) patients in KwaZulu-Natal, South Africa.南非夸祖鲁 - 纳塔尔省广泛耐药结核病(XDR-TB)患者的空间分布。
PLoS One. 2017 Oct 13;12(10):e0181797. doi: 10.1371/journal.pone.0181797. eCollection 2017.